newsfilter
← Latest News
GlobeNewswire·

Aravive Receives Third Development Milestone from 3D Medicines

HOUSTON, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Aravive Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced that it received a $6